[References]　Coordinated Glucose–Lipid Metabolic Rewiring in Cancer Progression

  1. D. Hanahan, Cell, 2026, Online ahead of print, DOI: 10.1016/j.cell.2025.12.049
  2. C. Swanton et al., Cell, 2024, 187(7), 1589–1616.
  3. F. Li and M. C. Simon, Dev. Cell, 2020, 54(2), 183–195.
  4. O. Warburg, Science, 1956, 123(3191), 309–314.
  5. E. C. Lien et al., Nature, 2021, 599(7884), 302–307.
  6. M. G. Vander Heiden et al., Science, 2010, 329(5998), 1492–1499.
  7. Y. Mao et al., Cell Rep., 2024, 43(12), 115064.
  8. X. Xu et al., Exp. Mol. Med., 2023, 55(7), 1357–1370.
  9. X. Mao et al., Cell Death Dis., 2025, 16(1), 182.
  10. C. Cheng et al., Cancer Cell, 2015, 28(5), 569–581.
  11. R. Pérez-Tomás and I. Pérez-Guillén, Cancers (Basel), 2020, 12(11), 3244.
  12. U. Thamrongwaranggoon et al., In Vivo, 2021, 35(1), 267–274.
  13. U. Thamrongwaranggoon et al., Biochem. Biophys. Res. Commun., 2017, 484(2), 409–415.
  14. U. Thonsri et al., Anticancer Res., 2020, 40(9), 5115–5124.
  15. U. Thonsri et al., Histol. Histopathol., 2017, 32(5), 503–510.
  16. P. Dana et al., Cell. Oncol. (Dordr.), 2020, 43(2), 211–222.
  17. U. Thamrongwaranggoon et al., Cancer Sci., 2023, 114(4), 1541–1555.
  18. C. Saengboonmee et al., Cancer Epidemiol., 2015, 39(3), 274–278.
  19. C. Saengboonmee et al., Nutr. Cancer, 2022, 74(5), 1734–1744.
  20. C. Saengboonmee et al., Sci. Rep., 2016, 6, 18995.
  21. C. Phoomak et al., Sci. Rep., 2017, 7, 43842.
  22. S. Pati et al., Cancers (Basel), 2023, 15(2), 485.
  23. A. Szutowicz et al., Br. J. Cancer, 1979, 39(6), 681–687.
  24. F. Röhrig and A. Schulze, Nat. Rev. Cancer, 2016, 16(11), 732–749.
  25. S. Saisomboon et al., Biochim. Biophys. Acta Mol. Basis Dis., 2023, 1869(5), 166694.
  26. X. Sun et al., Front. Immunol., 2024, 15, 1477267.
  27. J. Tomacha et al., Front. Pharmacol., 2021, 12, 696961.
  28. G. Medes et al., Cancer Res., 1953, 13(1), 27–29.
  29. Y. S. Park et al., Clin. Chim. Acta, 2011, 412(21-22), 1978–1982.
  30. S. Saisomboon et al., Int. J. Mol. Sci., 2024, 25(18), 10170.
  31. C. Coyle et al., Ann. Oncol., 2016, 27(12), 2184–2195.
  32. R. Shekhawat and C. C. Mandal, Curr. Cancer Drug Targets, 2021, 21(6), 476–494.
  33. C. Saengboonmee et al., Anticancer Res., 2017, 37(1), 115–123.
  34. P. Boonnate et al., Anticancer Res., 2021, 41(7), 3389–3400.
前のページへ戻る
TOP